Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury (NCT02891941) | Clinical Trial Compass
TerminatedNot Applicable
Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury
Stopped: Funding withdrawn
United States10 participantsStarted 2013-06
Plain-language summary
This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders \[i.e., major depression (MD\], cognitive disorders \[i.e., executive function deficits (EFD)\], and functional impairment following repetitive/mild traumatic brain injury (MTBI).
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Have sustained a closed head injury, defined as externally inflicted trauma without skull fracture;
. Have a Glasgow Coma Scale (GCS) score 13 or above
. Meet the American Congress of Rehabilitation Medicine criteria for mild traumatic brain injury
. Have experienced the last injury within 1 month
. Be in excellent/good medical health as assessed by the General Medical Health Rating (GMHR) scale
. Have sufficient cognitive capacity to provide informed consent
. Be between 18-65 years of age and
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Specific biomarkers (alone or in combination) assessed 3 months after MTBI
Timeframe: 3 months after MTBI.
2
Specific biomarkers (alone or in combination) assessed 6 months after MTBI.